effects of semaglutide on kidneys semaglutide, empagliflozin and their combination renal diffusion-weighted MRI and total kidney volume in patients with type 2 diabetes: a post hoc analysis from a 32 week randomised trial Patients with type 2 diabetes

Lymphoma remissions caused by anti-CD19 chimeric antigen receptor T cells are associated with high serum interleukin-15 levels

Expanded obesity drug coverage can increase Medicaid spending and put pressure on overall state budgets, and states are now facing tighter budget conditions and longer-term fiscal uncertainty, due in part to the federal Medicaid cuts in the 2025 reconciliation law, causing state Medicaid programs to re-evaluate their obesity drug coverage

Use the calculator only when: The medication is supplied in a vial The concentration is clearly listed in mg/mL You have a prescribed dose in milligrams You are using a U-100 syringe as instructed The result agrees with the pharmacy directions Questions About Semaglutide Dosing or Your Prescription

After a substantial reduction in body weight during 68 weeks of treatment with once-weekly subcutaneous semaglutide 2.4 mg and lifestyle intervention, withdrawal led to most of the weight loss being regained within 1 year, reinforcing the need for continued treatment to maintain weight loss and cardiometabolic benefits [211]

You must be vigilant when taking semaglutide, especially with insulin or insulin secretagogues to avoid severe hypoglycemia

Theme 3: Off-Label Use in Type 1 Diabetes (T1D) Although GLP-1s are not approved for people with T1D, some individuals with T1D are using them off-label, particularly if they live with obesity, strong insulin resistance, or significant post-meal blood sugar spikes